NeuroMetrix is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions, including mobile apps, enterprise software, and cloud-based systems. It operates two commercial brands Quell (wearable neuromodulation platform) and DPNCheck (point-of-care screening test for peripheral neuropathy). NeuroMetrix was founded in 1996 and is based in Woburn, Massachusetts.
